Literature DB >> 21496838

Renal cell carcinoma as first and second primary cancer: etiological clues from the Swedish Family-Cancer Database.

Hao Liu1, Kari Hemminki, Jan Sundquist.   

Abstract

PURPOSE: An increasing incidence and improved prognosis of kidney cancer have led to concern about second primary malignancies. The study of multiple primary malignancies is also important since the association of certain malignancies may guide the search for germline alterations and environmental risk factors. We evaluated bidirectional associations between renal cell carcinoma and other primary cancers.
MATERIALS AND METHODS: We studied 8,030 patients with renal cell carcinoma based on the Swedish Family-Cancer Database. The SIR of second cancer was calculated by comparing it to the rate of first cancers. Followup was started in 1993 and continued through 2006.
RESULTS: A total of 677 patients had second cancers after the first renal cell carcinoma, including 89 second renal cell carcinomas. In 776 patients renal cell carcinoma was diagnosed after another primary cancer. Histology concordant renal cell carcinoma pairs showed a SIR of 31.04 and 15.15 after clear cell and total renal cell carcinoma, respectively. The highest SIR of 132.46 was noted for synchronous contralateral clear cell renal cell carcinoma. A reciprocally increased risk of renal cell carcinoma was seen after lung, breast, prostate, bladder, thyroid gland, adrenal gland and nervous system cancer as well as after melanoma and nonHodgkin's lymphoma. Clear cell renal cell carcinoma was also in excess after brain hemangioblastoma with a SIR of 70.79.
CONCLUSIONS: High risk was found for histology concordant renal cell carcinoma pairs and contralateral renal cell carcinoma. Bidirectional associations of renal cell carcinoma with many other cancers may imply etiological sharing. von Hippel-Lindau syndrome may explain the excess of renal cell carcinoma after brain hemangioblastoma.
Copyright © 2011 American Urological Association Education and Research, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21496838     DOI: 10.1016/j.juro.2011.02.001

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  13 in total

1.  Relapsing Long-Lasting Garcin Syndrome Revealing Skull Base Diffuse B Cell Lymphoma: The Diagnosis through the "Hartel's Route".

Authors:  Barbara Casolla; Serena Candela; Antonio Ciacciarelli; Ludovico Ciolli; Andrea Romano; Michele Acqui; Maria Christina Cox; Giuliano Sette; Francesco Orzi
Journal:  J Neurol Surg B Skull Base       Date:  2018-06-08

2.  Antihypertensive medication use and risk of renal cell carcinoma.

Authors:  Joanne S Colt; Jonathan N Hofmann; Kendra Schwartz; Wong-Ho Chow; Barry I Graubard; Faith Davis; Julie Ruterbusch; Sonja Berndt; Mark P Purdue
Journal:  Cancer Causes Control       Date:  2017-02-21       Impact factor: 2.506

3.  Renal Cell Carcinoma With Pulmonary Metastasis and Metachronous Non-Small Cell Lung Cancer.

Authors:  Isaac A Bowman; Ivan Pedrosa; Payal Kapur; James Brugarolas
Journal:  Clin Genitourin Cancer       Date:  2017-02-06       Impact factor: 2.872

4.  Risk of subsequent primary thyroid cancer after another malignancy: latency trends in a population-based study.

Authors:  Geeta Lal; Megan Groff; James R Howe; Ronald J Weigel; Sonia L Sugg; Charles F Lynch
Journal:  Ann Surg Oncol       Date:  2012-01-07       Impact factor: 5.344

5.  An investigation of risk factors for renal cell carcinoma by histologic subtype in two case-control studies.

Authors:  Mark P Purdue; Lee E Moore; Maria J Merino; Paolo Boffetta; Joanne S Colt; Kendra L Schwartz; Vladimir Bencko; Faith G Davis; Barry I Graubard; Vladimir Janout; Julie J Ruterbusch; Jennifer Beebe-Dimmer; Michele L Cote; Brian Shuch; Dana Mates; Jonathan N Hofmann; Lenka Foretova; Nathaniel Rothman; Neonilia Szeszenia-Dabrowska; Vsevolod Matveev; Sholom Wacholder; David Zaridze; W Marston Linehan; Paul Brennan; Wong-Ho Chow
Journal:  Int J Cancer       Date:  2013-01-15       Impact factor: 7.396

6.  Radiation induced esophageal adenocarcinoma in a woman previously treated for breast cancer and renal cell carcinoma.

Authors:  Soundouss Raissouni; Ferdaous Raissouni; Ghizlane Rais; Meryem Aitelhaj; Siham Lkhoyaali; Rachida Latib; Amina Mohtaram; Fadoua Rais; Hind Mrabti; Nawal Kabbaj; Naima Amrani; Hassan Errihani
Journal:  BMC Res Notes       Date:  2012-08-09

7.  A case-control study of occupation/industry and renal cell carcinoma risk.

Authors:  Sara Karami; Joanne S Colt; Kendra Schwartz; Faith G Davis; Julie J Ruterbusch; Stella S Munuo; Sholom Wacholder; Patricia A Stewart; Barry I Graubard; Nathanial Rothman; Wong-Ho Chow; Mark P Purdue
Journal:  BMC Cancer       Date:  2012-08-08       Impact factor: 4.430

8.  Risk of Second Primary Cancers in Multiple Myeloma Survivors in German and Swedish Cancer Registries.

Authors:  Tianhui Chen; Mahdi Fallah; Hermann Brenner; Lina Jansen; Elias K Mai; Felipe A Castro; Alexander Katalinic; Katharina Emrich; Bernd Holleczek; Karla Geiss; Andrea Eberle; Kristina Sundquist; Kari Hemminki
Journal:  Sci Rep       Date:  2016-02-24       Impact factor: 4.379

9.  Second Primary Cancer Risk among Kidney Cancer Patients in Korea: A Population-Based Cohort Study.

Authors:  Jae Young Joung; Whi-An Kwon; Jiwon Lim; Chang-Mo Oh; Kyu-Won Jung; Sung Han Kim; Ho Kyung Seo; Weon Seo Park; Jinsoo Chung; Kang Hyun Lee; Young-Joo Won
Journal:  Cancer Res Treat       Date:  2017-04-19       Impact factor: 4.679

10.  Second Primary Cancers After Kidney Cancers, and Kidney Cancers as Second Primary Cancers.

Authors:  Guoqiao Zheng; Kristina Sundquist; Jan Sundquist; Tianhui Chen; Asta Försti; Otto Hemminki; Kari Hemminki
Journal:  Eur Urol Open Sci       Date:  2021-01-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.